Table 1.
Immunohistochemical analysis of human cutaneous SCC tissues.
| Case | Age | Sex | Site | p-EGFR | p-Akt | p-Stat3 | EMSA Stat3 |
|---|---|---|---|---|---|---|---|
| 1 | 64 | M | Back, primary lesion | + | − | + | N.D. |
| 1′ | Lymph node, metastasis of case 1 | + | − | + | N.D. | ||
| 2 | 89 | F | Face | + | + | + | N.D. |
| 3 | 41 | F | Foot | − | + | − | N.D. |
| 4 | 65 | M | Head | + | + | + | N.D. |
| 5 | 61 | F | Hand, primary lesion | + | + | + | + |
| 5′ | Lymph node, metastasis of case 5 | + | + | + | + | ||
| 6 | 58 | M | Thigh | − | + | − | − |
| 7 | 81 | M | Foot finger | + | + | + | + |
| 8 | 54 | F | Lower leg | − | − | − | N.D. |
| 9 | 41 | F | Hand finger | + | − | + | N.D. |
| 10 | 72 | M | Forehead | + | + | + | + |
| 11 | 81 | F | Face | + | − | + | N.D. |
| 12 | 72 | F | Face | + | + | + | N.D. |
| 13 | 75 | M | Face | + | + | + | N.D. |
| 14 | 90 | F | Face | − | − | − | N.D. |
| 15 | 62 | M | Face | + | + | + | N.D. |
| 16 | 64 | M | Face | + | + | + | N.D. |
| 17 | 80 | F | Face | − | − | + | N.D. |
| 18 | 96 | F | Face | + | + | + | N.D. |
| 19 | 88 | M | Head | − | + | + | N.D. |
| 20 | 81 | M | Lower leg | + | + | + | N.D. |
| 21 | 77 | M | Head | + | + | + | N.D. |
| 22 | 89 | F | Head | + | − | + | N.D. |
| 23 | 71 | F | Face | − | + | + | N.D. |
| 24 | 93 | F | Vulva | + | + | + | N.D. |
| 25 | 71 | M | Foot back | + | + | + | N.D. |
| 26 | 81 | M | Head | + | − | + | N.D. |
| 27 | 55 | F | Sole | − | − | + | N.D. |
| 28 | 101 | M | Face | + | − | + | N.D. |
| 29 | 87 | F | Forearm | + | − | + | N.D. |
| 29′ | Lymph node, metastasis of case 29 | + | + | + | N.D. | ||
| 30 | 73 | M | Thigh | − | − | + | N.D. |
| 31 | 87 | M | Scrotum | + | − | + | N.D. |
| 32 | 74 | F | Lip | − | − | − | N.D. |
|
| |||||||
| Positive cases/Total | 25/35 | 20/35 | 30/35 | 4/5 | |||
+: positive, −: negative, N.D.: not done.